Return to homepage Skip to navigation Skip to site search Skip to main content Skip to footer


Abertay cancer scientists host inaugural Biomarkers conference

1 October 2014

Experts in the field of biomarker research from universities across the UK - as well as representatives from industry - will gather in Dundee today (October 1) and tomorrow (October 2) to discuss how best to optimise biomarker potential in personalised healthcare.

Biomarkers are measurable indicators of normal biological processes, pathogenic processes, or pharmacological responses to a therapeutic intervention.

Abertay is a leading member of an international consortium that has been established to develop and validate novel biomarkers and devices for the early diagnosis of breast cancer, and is hosting this event.

The conference will focus on the role of circulating biomarkers in oncology with a particular emphasis on circulating tumour cells, circulating free DNA, and circulating micro RNA.

It will be the first in a series of annual conferences to be held at Abertay.

Speaking ahead of the event, Principal and Vice-Chancellor of Abertay University - Professor Nigel Seaton - said:

“I am glad to have the opportunity to open the inaugural Circulating Biomarkers conference.

“This is an important - and growing - area of biotechnology, offering the prospect of earlier diagnosis for breast cancer and other life-threatening diseases, and it’s a major focus of our research at Abertay.

“Collaboration is central to success in this area, so it’s a particular pleasure to welcome colleagues from around the UK.”

Professor Nikolai Zhelev, Director of the Centre for Molecular Cellular Biosensor Research (CMCBR) at Abertay University and organiser of the event, said:

"I am delighted that this event has attracted such renowned experts from around the UK and am also pleased that some of our students have expressed interest in the conference and will be attending.

“It will be a great opportunity for them to hear from some of the most forward-thinking people in this field, and I am sure it will lead to some interesting discussions and new collaborations.”


For media enquiries please contact Kirsty Cameron T: 01382 308935 M: 07972172158 E:

Notes to Editors:

Speaking at the two-day event will be leading academics from the universities of Abertay, Cambridge, Manchester, Leicester, Glasgow, Edinburgh, Dundee, Sheffield, York and London.

There will also be representatives from the National University of Ireland, Horizon Diagnostics, Cancer Research UK, Cizzle Biotech, Agena Bioscience, and the NHS.

Back to News